Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study

References

• AGIS Investigations2000The Advanced Glaucoma Intervention Study (AGIS): The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol1304294011024415
   PubMed Web of Science ®Google Scholar
• AlmAWidengardIKjellgrenD1995Latanoprost administrated once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timololBr J Ophthalmol791267880782
   PubMed Web of Science ®Google Scholar
• AriciMKTopalkanaAGullerC1998Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressureInt Ophthalmol22374210090447
   PubMed Web of Science ®Google Scholar
• BarnebeyHKwokSY2000Patients’ acceptance of switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice settingClin Ther2212041211110231
   PubMed Web of Science ®Google Scholar
• BrubakerRFIngnamCJSchoffEO2000Comparison of the efficacy of betaxolol -brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjectsOphthalmology107283710690826
   PubMed Web of Science ®Google Scholar
• BucciMG1999Italian Latanoprost Study Group. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multi-center study in patients with open-angle glaucomaJ Glaucoma8243010084271
   PubMed Web of Science ®Google Scholar
• CamrasCBAlmAWatsonP1996Latanoprost, a prostgalndin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study GroupsOphthalmology1031916248942890
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study Group1998The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol1264985059780094
   PubMed Web of Science ®Google Scholar
• DeSantisL2000Preclinical overview of brinzolamideSurv Ophthalmol44s1192910665514
   PubMed Web of Science ®Google Scholar
• HeijlALaskeMCBengtssonB2002Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol1202002
   Google Scholar
• HeyrehSSPodhajskyPZimmermanMB1999Beta-blocker eye drops and nocturnal arterial hypotensionAm J Ophthalmol128301910511024
   PubMed Web of Science ®Google Scholar
• HigginbothamEJFeldmanRStilesM2002Fixed Combination Investigative Group. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trialArch Ophthalmol1209152212096962
   PubMed Web of Science ®Google Scholar
• HollóGChiselitaDPetkovaN2006The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucomaEur J Ophthalmol168162317191187
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJ2002The Ocular Hypertension Treatment Study. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol1207011312049574
   PubMed Web of Science ®Google Scholar
• KobayashiHKobayashiKOkinamiS2004Hypotensive effect and subjective symptoms after substitution of 1% dorzolamide by 1% brinzolamideJpn J Clin Ophthalmol582059
   Google Scholar
• Kobelt-NguyenGGerdthamUGAlmA1998Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational chart review of newly diagnosed patients in Sweden and the United StatesJ Glaucoma7951049559495
   PubMed Web of Science ®Google Scholar
• KubotaMHaraTKubotaS2004Ocular hypotensive effect of brinzolamide after switching from dorzolamideJpn J Clin Ophthalmol583013
   Google Scholar
• LarssonLI2001Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertensionJ Glaucoma101091411316092
   PubMed Web of Science ®Google Scholar
• MaoLKStewartWCShieldsMB1991Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucomaAm J Ophthalmol1115151985490
   PubMed Web of Science ®Google Scholar
• MarchWFOchsnerLI2000The Brinzolamide Long-Term Therapy Study Group. The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertensionAm J Ophthalmol1291364310682964
   PubMed Web of Science ®Google Scholar
• Martinez-de-la-CasaJMGarcia-FeijooCJMendez-HernandezC2004Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy. Three-month comparison of efficacy and safetyCurr Med Res Opin201333915383180
   PubMed Web of Science ®Google Scholar
• MichaudJEFrirenB2001International Brinzolamide Adjunctive Study Group. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertensionAm J Ophthalmol1322354311476685
   PubMed Web of Science ®Google Scholar
• NelsonWLFraunfelderFTSillsJM1986Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978–85Am J Ophthalmol102606113777080
   PubMed Web of Science ®Google Scholar
• O’ConnorDJMartoneJFMeadA2002Additive intraocular pressure lowering effect of various medications with latanoprostAm J Ophthalmol133836712036683
   PubMed Web of Science ®Google Scholar
• SallK2000The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. The Brinzolamide Primary Therapy Study GroupSurv Ophthalmol44s1556210665518
   PubMed Web of Science ®Google Scholar
• SchenkerHMaloneySLissC1999Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucomaClin Therapeutics2113847
   PubMed Web of Science ®Google Scholar
• SeongGJLeeSCLeeJH2001Comparisons of intraocular-pressure- lowering efficacy and side-effects of 2% dorzolamide and 1% brinzolamideOphthalmologica2151889111340389
   PubMed Web of Science ®Google Scholar
• ShinD2000Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapySurv Ophthalmol44s163810665519
   PubMed Web of Science ®Google Scholar
• ShojiNOgataHSuyamaH2005Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label studyCurr Med Res Opin21503715899098
   PubMed Web of Science ®Google Scholar
• SilverLH2000Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: Results from two multicenter comfort studies. The Brinzolamide Comfort Study GroupSurv Ophthalmol44s141510665516
   PubMed Web of Science ®Google Scholar
• SilverLH1998The Brinzolamide Primary Therapy Study Group. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertensionAm J Ophthalmol12640089744373
   PubMed Web of Science ®Google Scholar
• StewartWCDayDGStewartJA2004Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% versus placebo in primary open-angle glaucoma and ocular hypertension subjectsEye189051015002017
   PubMed Web of Science ®Google Scholar
• TsukamotoHNomaHMatuyamaS2005The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucomaJ Ocul Pharmacol Ther21170315857284
   PubMed Web of Science ®Google Scholar
• van der ValkRWebersCABSchoutenJSAG2005Intraocular pressure-lowering effects of all commonly used glaucoma drugs. A meta-analysis of randomized clinical trialsOphthalmology11211778515921747
   PubMed Web of Science ®Google Scholar